| |
|
|
| |
Description
Ingelvac PRRS MLV is a vaccine that is proven safe in pigs as well as gilts and sows at any stage of production in PRRS positive herds. It provides cross protection against heterologous (including Lelystad virus) and homologous challenge and has shown to significantly reduce reproductive failure and respiratory disease due to PRRS virus.
Features
Safe in pigs, gilts and sows at any stage of production.
Aids in the reduction of both repro-ductive and respiratory forms of the disease caused by PRRS virus.
Proven cross protection against heterologous (including Lelystad virus) and homologous challenge.
Easy to use, cost effective and field proven against respiratory and reproductive forms of PRRS Virus.
Benefits
Long-lasting immunity.
Whole herd or population based PRRS control program advantages.
Significantly reduces reproductive failure due to PRRS virus.
Reduces PRRS viremia in challenged animals.
Gilt stabilization/acclimatization program advantages.
Advantages
Safe at any stage of production.
Controls both respiratory and reproductive forms of PRRS.
Dosage & Administration
Ingelvac PRRS MLV utilizes the same intramuscular (IM) dose size (2 mL) for pigs, adult breeding-age or pregnant females.
Pigs, gilts and sows: Ingelvac PRRS MLV is recommended for use in healthy susceptible swine in PRRS virus-positive herds according to label direction. Using aseptic technique, administer a single 2 mL dose intramuscularly (IM) to aid in the reduction of disease associated with PRRS. The duration of immunity is throughout the finishing or gestation period, or up to 4 months post-vaccination.
The vaccine can be used at any stage of production. Revaccination of the whole herd can occur every 3-4 months or as directed by your veterinarian.
DO NOT VACCINATE BOARS.
Precautions
For veterinary use only; for use only in swine as directed.
See label insert for complete information.
Highlights
- Safe for use at any stage of production.
- Modified live virus vaccine with proven efficacy.
- Demonstrated cross protection against heterologous (including Lelystad virus) and homologous challenge.
Uses
Whole herd or population based PRRS control programs.
Replacement gilt immunization and preparation.
Reproductive maintenance vaccination program in sows.
Warning
Do not vaccinate boars.
Anaphylactoid reactions may occur.
Antidote: administer epinephrine.
Vaccinated pigs, sows or gilts are not to be harvested for human
consumption before 21 days post-vaccination. Ingelvac PRRS MLV is not recommended for use in PRRS negative (naive) herds.
|
|
| |
Packaging Options (top) |
|
| |
Product Name |
Code |
Unit
Size |
Case
Size |
Case
Weight |
 |
Ingelvac® PRRS MLV
|
124-511
|
Size: 20 mL 10 dose
|
-
|
-
|
|
Ingelvac® PRRS MLV
|
124-531
|
100 mL 50 dose
|
-
|
-
|
|
-
|
-
|
-
|
-
|
-
|
|
-
|
-
|
-
|
-
|
-
|
|
-
|
-
|
-
|
-
|
-
|
 |
 |
|
|
|
|
|
|
|
|
|
|
| |
| |
|
|
| |
Contact Information For INGELVAC® PRRS MLV (top) |
|
| |
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
800-821-7467 Information
800-325-9167 Sales
816-236-2717
email: trudy.luther@boehringer-ingelheim.com
internet: http://www.bi-vetmedica.com
|
|
| |
|
|
| |
General Product Information Documents (top) |
|
| |
|
|
| |
Product Image for INGELVAC® PRRS MLV (top) |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
Related Technical Bulletins (top) |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|